Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer C Spencer
Cosette M Wheeler

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2024
Promise and Perils of Primary HPV TestingJennifer C Spencer, Cosette M Wheeler
Nature Clinical Practice. Oncology|March 30, 2007
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testingCosette M Wheeler
Ethnicity & Disease|August 9, 2007
Human papillomavirus vaccines: who will pay, who will receive, when to administer?Debbie Saslow, Cosette M Wheeler
Genes, Chromosomes & Cancer|June 10, 2004
Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotypeHugo Arias-Pulido, Nancy Joste, Cosette M Wheeler
American Journal of Obstetrics and Gynecology|November 18, 2004
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancerPhilip E Castle, Mark Schiffman, Cosette M Wheeler
The Journal of Infectious Diseases|October 2, 2002
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalitiesMark Schiffman, Cosette M Wheeler, Philip E Castle, et al.
American Journal of Epidemiology|October 31, 2014
Concurrence of multiple human papillomavirus infections in a large US population-based cohortZihua Yang, Jack Cuzick, William C Hunt, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
The Journal of Infectious Diseases|October 17, 2006
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancerCosette M Wheeler, William C Hunt, Mark Schiffman, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 2024
Promise and Perils of Primary HPV TestingJennifer C Spencer, Cosette M Wheeler
Nature Clinical Practice. Oncology|March 30, 2007
Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testingCosette M Wheeler
Ethnicity & Disease|August 9, 2007
Human papillomavirus vaccines: who will pay, who will receive, when to administer?Debbie Saslow, Cosette M Wheeler
Genes, Chromosomes & Cancer|June 10, 2004
Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotypeHugo Arias-Pulido, Nancy Joste, Cosette M Wheeler
American Journal of Obstetrics and Gynecology|November 18, 2004
Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancerPhilip E Castle, Mark Schiffman, Cosette M Wheeler
The Journal of Infectious Diseases|October 2, 2002
Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalitiesMark Schiffman, Cosette M Wheeler, Philip E Castle, et al.
American Journal of Epidemiology|October 31, 2014
Concurrence of multiple human papillomavirus infections in a large US population-based cohortZihua Yang, Jack Cuzick, William C Hunt, et al.
Journal of the National Cancer Institute|July 21, 2005
Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalitiesPhilip E Castle, Diane Solomon, Mark Schiffman, et al.
Obstetrics and Gynecology|December 24, 2008
Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2Philip E Castle, Mark Schiffman, Cosette M Wheeler, et al.
The Journal of Infectious Diseases|October 17, 2006
Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancerCosette M Wheeler, William C Hunt, Mark Schiffman, et al.
Pageof 20